Cited by 1,089Genetic Neurodegenerative DiseasesGenetic factors in colorectal cancerGenetics and Neurodevelopmental Disorders

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Trinucleotide repeat length instability and age of onset in Huntington's disease

Duyao, M., Ambrose, C., Myers, R., Novelletto, A., Persichetti, F., Frontali, M., Folstein, S., Ross, C., Franz, M., Abbott, M., Gray, J., Conneally, P., Young, A., Penney, J., Hollingsworth, Z., Shoulson, I., Lazzarini, A., Falek, A., Koroshetz, W., Sax, D., Bird, E., Vonsattel, J., Bonilla, E., Alvir, J., Bickham Conde, J., Cha, J.-H., Dure, L., Gomez, F., Ramos, M., Sanchez-Ramos, J., Snodgrass, S., de Young, M., Wexler, N., Moscowitz, C., Penchaszadeh, G., MacFarlane, H., Anderson, M., Jenkins, B., Srinidhi, J., Barnes, G., Gusella, J., MacDonald, M.·1993·Nature Genetics

DOI 10.1038/ng0893-387

Open this paper in CoChat — free account

Abstract

The initial observation of an expanded and unstable trinucleotide repeat in the Huntington's disease gene has now been confirmed and extended in 150 independent Huntington's disease families. HD chromosomes contained 37-86 repeat units, whereas normal chromosomes displayed 11-34 repeats. The HD repeat length was inversely correlated with the age of onset of the disorder. The HD repeat was unstable in more than 80% of meiotic transmissions showing both increases and decreases in size with the largest increases occurring in paternal transmissions. The targeting of spermatogenesis as a particular source of repeat instability is reflected in the repeat distribution of HD sperm DNA. The analysis of the length and instability of individual repeats in members of these families has profound implications for presymptomatic diagnosis.

Integrity signals

Registry

Crossref · 10.1038/ng0893-387

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Self-citation
Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome
Verkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.
Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055
Self-citation
Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy
Spada, A. L., Wilson, E. M., Lubahn, D. B., Harding, A., & Fischbeck, K. (1991) · Nature · doi:10.1038/352077a0 · Cited by 2,801
Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member
Brook, J. D., McCurrach, M. E., Harley, H. G., Buckler, A., Church, D. M., Aburatani, H., Hunter, K. W., Stanton, V. P., Thirion, J., Hudson, T. J., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90154-5 · Cited by 2,754
A polymorphic DNA marker genetically linked to Huntington's disease
Gusella, J. F., Wexler, N. S., Conneally, P. M., Naylor, S. L., Anderson, M. A., Tanzi, R. E., Watkins, P. C., Ottina, K. A., Wallace, M. R., Sakaguchi, A. Y., et al. (1983) · Nature · doi:10.1038/306234a0 · Cited by 2,340
Self-citation
Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox
Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Pieretti, M., Sutcliffe, J. S., Richards, S., Verkert, A. J. M. H., Holden, J. J. A., Fenwick, R. G., Warren, S. T., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90283-5 · Cited by 2,080
Myotonic Dystrophy Mutation: an Unstable CTG Repeat in the 3′ Untranslated region of the Gene
Mahadevan, M. S., Tsilfidis, C., Sabourin, L. A., Shutler, G., Amemiya, C. T., Jansen, G., Neville, C., Narang, M. A., Barceló, J. M., O'Hoy, K., et al. (1992) · Science · doi:10.1126/science.1546325 · Cited by 1,656
Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1
Orr, H. T., Chung, M.-Y., Banfi, S., Kwiatkowski, T. J., Servadio, A., Beaudet, A. L., McCall, A. E., Duvick, L. A., Ranum, L. P. W., & Zoghbi, H. Y. (1993) · Nature Genetics · doi:10.1038/ng0793-221 · Cited by 1,632
An Unstable Triplet Repeat in a Gene Related to Myotonic Muscular Dystrophy
Fu, Y., Pizzuti, A., Fenwick, R. G., King, J., Rajnarayan, S., Dunne, P. W., Dubel, J., Nasser, G. A., Ashizawa, T., de Jong, P., et al. (1992) · Science · doi:10.1126/science.1546326 · Cited by 1,453

Flagged first, then by citations

Show all 35 references

Research works printed but not linked: 1

SAS/STAT User's Guide, Version 6, 4th edn, Vol.2 (SAS Institute Inc., Cary, North Carolina, 1989).

Sorted by citations

Items 501–600 of 998

Polyglutamine repeats and β‐helix structure: Molecular dynamics study
Merlino, A., Esposito, L., & Vitagliano, L. (2006) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.20941 · Cited by 31
Novel Metabolite Biomarkers of Huntington’s Disease As Detected by High-Resolution Mass Spectrometry
Graham, S. F., Kumar, P., Bahado-Singh, R. O., Robinson, A., Mann, D. M. A., & Green, B. D. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00049 · Cited by 31
Unstable Triplet Repeat Diseases
Monckton, D. G., & Caskey, C. T. (1995) · Circulation · doi:10.1161/01.cir.91.2.513 · Cited by 34
De Novo Appearance and “Strain” Formation of Yeast Prion [PSI+] Are Regulated by the Heat-Shock Transcription Factor
Park, K.-W., Hahn, J., Fan, Q., Thiele, D. J., & Li, L. (2006) · Genetics · doi:10.1534/genetics.105.054221 · Cited by 32
Diagnosis of “sporadic” Huntington's disease
Dürr, A., Dodé, C., Hahn‐Barma, V., Pécheux, C., Pillon, B., Feingold, J., Jc, K., Agid, Y., & Brice, A. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)00250-r · Cited by 31
Apathy and Depression in Huntington’s Disease: Distinct Longitudinal Trajectories and Clinical Correlates
Connors, M. H., Teixeira-Pinto, A. M., & Loy, C. T. (2022) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.21070191 · Cited by 30
A CAG repeat-targeting artificial miRNA lowers the mutant huntingtin level in the YAC128 model of Huntington's disease
Kotowska‐Zimmer, A., Przybył, Ł., Pewińska, M., Suszyńska-Zajczyk, J., Wronka, D., Figiel, M., & Olejniczak, M. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.04.031 · Cited by 33
Conformational dynamics and self-association of intrinsically disordered Huntingtin exon 1 in cells
Büning, S., Sharma, A. A., Vachharajani, S., Newcombe, E. A., Ormsby, A. R., Gao, M., Gnutt, D., Vöpel, T., Hatters, D. M., & Ebbinghaus, S. (2017) · Physical Chemistry Chemical Physics · doi:10.1039/c6cp08167c · Cited by 30
Growth charts for young children with neurofibromatosis 1 (NF1)
Szudek, J., Birch, P. H., & Friedman, J. M. (2000) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(20000529)92:3 · Cited by 28
Null Alleles at the Huntington Disease Locus: Implications for Diagnostics and CAG Repeat Instability
Williams, L. C., Hegde, M., Nagappan, R., Faull, R. L. M., Giles, J., Winship, I., Snow, K., & Love, D. R. (2000) · Genetic Testing · doi:10.1089/109065700316480 · Cited by 30
Solution Structures of the Huntington's Disease DNA Triplets, (CAG) n
Mariappan, S. V. S., Silks, L. A., Chen, X., Springer, P. A., Wu, R., Moyzis, R. K., Bradbury, E. M., Garcı́a, A. E., & Gupta, G. (1998) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.1998.10508988 · Cited by 30
Identification and Characterization of the Miniature Pig Huntington's Disease Gene Homolog: Evidence for Conservation and Polymorphism in the CAG Triplet Repeat
Matsuyama, N., Hadano, S., Onoe, K., Osuga, H., Showguchi-Miyata, J., Gondo, Y., & Ikeda, J. (2000) · Genomics · doi:10.1006/geno.2000.6317 · Cited by 29
Cystic fibrosis mutation frequencies in upstate New York
Shrimpton, A. E., Borowitz, D., & Swender, P. T. (1997) · Human Mutation · doi:10.1002/(sici)1098-1004(1997)10:6 · Cited by 17
Self-citation
Huntington disease--another chapter rewritten.
NANCE, M. A. (1996) · PubMed Central · Cited by 29
Machado-Joseph disease in four Chinese pedigrees
Zhou, Y., Takiyama, Y., Igarashi, S., Li, Y. F., Zhou, B. Y., Gui, D. C., Endo, K., Tanaka, H., Chen, Z. H., Zhou, L. S., et al. (1997) · Neurology · doi:10.1212/wnl.48.2.482 · Cited by 29
Multiple Levels of Single-Strand Slippage at Cetacean Tri- and Tetranucleotide Repeat Microsatellite Loci
Palsbøll, P. J., Bérubé, M., & Jørgensen, H. (1999) · Genetics · doi:10.1093/genetics/151.1.285 · Cited by 29
Huntington's Disease (HD): Neurodegeneration of Brodmann's Primary Visual Area 17 (BA17)
Rüb, U., Seidel, K., Vonsattel, J. P., Lange, H. W., Eisenmenger, W., Götz, M., Turco, D. D., Bouzrou, M., Korf, H., & Heinsen, H. (2014) · Brain Pathology · doi:10.1111/bpa.12237 · Cited by 30
Self-citation
Novel allele-specific quantification methods reveal no effects of adult onset CAG repeats on HTT mRNA and protein levels
Shin, A., Shin, B., Shin, J. W., Kim, K., Atwal, R. S., Hope, J. M., Gillis, T., Leszyk, J., Shaffer, S. A., Lee, R., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx033 · Cited by 28
Self-citation
Structural imaging in premanifest and manifest Huntington disease
Scahill, R. I., André, R., Tabrizi, S. J., & Aylward, E. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-12-801893-4.00020-1 · Cited by 28
Astrocytes in Huntington’s Disease
Gray, M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9913-8_14 · Cited by 27
The Effects of Selective Inhibition of Histone Deacetylase 1 and 3 in Huntington’s Disease Mice
Hecklau, K., Mueller, S. G., Koch, S., Mehkary, M. H., Kilic, B., Harms, C., Boehm‐Sturm, P., & Yildirim, F. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.616886 · Cited by 28
Autophagy system as a potential therapeutic target for neurodegenerative diseases
Cui, M., Yoshimori, T., & Nakamura, S. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105308 · Cited by 29
Juvenile Huntington disease
Geevasinga, N., Richards, F., Jones, K., & Ryan, M. M. (2006) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.2006.00921.x · Cited by 28
Protection by dietary restriction in the YAC128 mouse model of Huntington's disease: Relation to genes regulating histone acetylation and HTT
Moreno, C. L., Ehrlich, M. E., & Mobbs, C. V. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.09.012 · Cited by 28
Chinese patients with Huntington's disease initially presenting with spinocerebellar ataxia
Dong, Y., Sun, Y., Liu, Z. ‐., Wang, N., Shi, S., & Wu, Z. (2012) · Clinical Genetics · doi:10.1111/j.1399-0004.2012.01927.x · Cited by 28
Mouse Models of Human CAG Repeat Disorders
Burright, E. N., Orr, H. T., & Clark, H. B. (1997) · Brain Pathology · doi:10.1111/j.1750-3639.1997.tb00896.x · Cited by 28
Genetics of dementia
Tsuang, D. W., & Bird, T. D. (2002) · Medical Clinics of North America · doi:10.1016/s0025-7125(02)00003-2 · Cited by 28
Mutant huntingtin protein decreases with CAG repeat expansion: implications for therapeutics and bioassays
Landles, C., Osborne, G. F., Phillips, J. M., Cañibano-Pico, M., Nita, I. M., Ali, N. S., Bobkov, K., Greene, J. R., Sathasivam, K., & Bates, G. P. (2024) · Brain Communications · doi:10.1093/braincomms/fcae410 · Cited by 23
Sequence-Level Analysis of the Major European Huntington Disease Haplotype
Lee, J., Kim, K., Shin, A., Chao, M. J., Elneel, K. A., Gillis, T., Mysore, J. S., Kaye, J., Zahed, H., Kratter, I. H., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.07.017 · Cited by 26
Self-citation
Mitochondrial fragmentation in neuronal degeneration: Toward an understanding of HD striatal susceptibility
Cherubini, M., & Ginés, S. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.042 · Cited by 28
Library preparation and MiSeq sequencing for the genotyping-by-sequencing of the Huntington disease HTT exon one trinucleotide repeat and the quantification of somatic mosaicism
Ciosi, M., Ciosi, M., Cumming, S. A., Mubarak, A., Symeonidi, E., Herzyk, P., McGuinness, D., Galbraith, J., Hamilton, G. M., & Monckton, D. G. (2018) · Protocol Exchange · doi:10.1038/protex.2018.089 · Cited by 27
Coenzyme Q10 and its effects in the treatment of neurodegenerative diseases
dos Santos, G. C., Antunes, L. M. G., dos Santos, A. C., & Bianchi, M. D. L. P. (2009) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s1984-82502009000400002 · Cited by 28
Monozygotic Twins Suffering from Huntington’s Disease Show Different Cognitive and Behavioural Symptoms
Gómez‐Esteban, J. C., Lezcano, E., Zarranz, J. J., Velasco, F., Garamendi, Í., Pérez, T., & Tijero, B. (2006) · European Neurology · doi:10.1159/000097006 · Cited by 27
Patients with features similar to Huntington's disease, without CAG expansion in huntingtin
Rosenblatt, A., Ranen, N. G., Rubinsztein, D. C., Stine, O. C., Margolis, R. L., Wagster, M. V., Bêcher, M. W., Rosser, A., Leggo, J., Hodges, J. R., et al. (1998) · Neurology · doi:10.1212/wnl.51.1.215 · Cited by 27
Self-citation
Comparative semi-automated analysis of (CAG) repeats in the Huntington disease gene: use of internal standards
Williams, L., Hedge, M., Herrera, G. M., Stapleton, P. M., & Love, D. R. (1999) · Molecular and Cellular Probes · doi:10.1006/mcpr.1999.0248 · Cited by 27
A Novel Huntington’s Disease Assessment Platform to Support Future Drug Discovery and Development
Wu, J., Möhle, L., Brüning, T., Eiriz, I., Rafehi, M., Stefan, K., Stefan, S. M., & Pahnke, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314763 · Cited by 25
Somatic CAG repeat instability in intermediate alleles of the HTT gene and its potential association with a clinical phenotype
de Sabando, A. R., Ciosi, M., Galbete, A., Cumming, S. A., Spanish HD Collaborative Group, Álvarez, V., Martínez‐Descals, A., Milà, M., Trujillo-Tiebas, M. J., López-Sendón, J. L., et al. (2024) · European Journal of Human Genetics · doi:10.1038/s41431-024-01546-6 · Cited by 26
Population-scale analysis of human microsatellites reveals novel sources of exonic variation
McIver, L. J., McCormick, J. F., Martin, A., Fondon, J. W., & Garner, H. R. (2012) · Gene · doi:10.1016/j.gene.2012.12.068 · Cited by 26
Dominant effects of the Huntington's disease HTT CAG repeat length are captured in gene-expression data sets by a continuous analysis mathematical modeling strategy
Lee, J., Galkina, E. I., Levantovsky, R. M., Fossale, E., Anderson, M. A., Gillis, T., Mysore, J. S., Coser, K. R., Shioda, T., Zhang, B., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt176 · Cited by 25
Self-citation
Fifteen years of experience in predictive testing for Huntington disease at a single testing center in Victoria, Australia
Trembath, M. K., Tassicker, R. J., Collins, V., Mansie, S., Sheffield, L. J., & Delatycki, M. B. (2006) · Genetics in Medicine · doi:10.1097/01.gim.0000245633.97952.f1 · Cited by 26
Huntingtin Aggregates in the Olfactory Bulb in Huntington’s Disease
Highet, B., Dieriks, B. V., Murray, H. C., Faull, R. L. M., & Curtis, M. A. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00261 · Cited by 26
Molecular pathology of dentatorubral--pallidoluysian atrophy
Kanazawa, I. (1999) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1999.0460 · Cited by 26
Origins and evolution of huntington disease chromosomes
Andrew, S. E., & Hayden, M. R. (1995) · Neurodegeneration · doi:10.1016/1055-8330(95)90013-6 · Cited by 26
IT15 gene expression in fetal human brain
Dure, L. S., Landwehrmeyer, G. B., Golden, J. A., McNeil, S. M., Ge, P., Aizawa, H., Huang, Q., Ambrose, C. M., Duyao, M. P., Bird, E. D., et al. (1994) · Brain Research · doi:10.1016/0006-8993(94)90860-5 · Cited by 26
Self-citation
Expanded glutamines and neurodegeneration – a gain of insight
Bates, G. P. (1996) · BioEssays · doi:10.1002/bies.950180303 · Cited by 26
Huntington's disease: testing the test
Read, A. (1993) · Nature Genetics · doi:10.1038/ng0893-329 · Cited by 26
Huntington's disease
Scherder, E., & Statema, M. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61990-3 · Cited by 26
Huntington's Disease and Repeating Trinucleotides
Gusella, J. F., & MacDonald, M. E. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405193302011 · Cited by 25
Self-citation
Extracellular Vesicles, Stem Cells and the Role of miRNAs in Neurodegeneration
MARATOVICH, B. A., Al-Yozbaki, M., George, A., Niyazova, R. Y., Sharipov, K. O., Byrne, L. J., & Wilson, C. M. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210817150141 · Cited by 27
Integrated multi-omics analysis of Huntington disease identifies pathways that modulate protein aggregation
Pradhan, S. S., Manohar, T. S., Saiswaroop, R., Bhagavatham, S. K. S., Pulukool, S. K., Rathnakumar, S., Kanikaram, S. P., Dandamudi, R. B., Pargaonkar, A., Joseph, P., et al. (2022) · Disease Models & Mechanisms · doi:10.1242/dmm.049492 · Cited by 25
Population stratification may bias analysis of PGC-1α as a modifier of age at Huntington disease motor onset
Ramos, E. M., Latourelle, J. C., Lee, J., Gillis, T., Mysore, J. S., Squitieri, F., Pardo, A. D., Donato, S. D., Hayden, M. R., Morrison, P. J., et al. (2012) · Human Genetics · doi:10.1007/s00439-012-1205-z · Cited by 25
Self-citation
Huntingtin Aggregates and Mitochondrial Pathology in Skeletal Muscle but not Heart of Late-Stage R6/2 Mice
Kojer, K., Hering, T., Bazenet, C. E., Weiss, A., Herrmann, F., Taanman, J., & Orth, M. (2019) · Journal of Huntington s Disease · doi:10.3233/jhd-180324 · Cited by 25
Huntington’s disease genetics
Myers, R. H. (2004) · Neurotherapeutics · doi:10.1007/bf03206609 · Cited by 25
Self-citation
Mouse Huntington’s Disease Homolog mRNA Levels: Variation and Allele Effects
DIXON, K. T., Cearley, J. A., Hunter, J. M., & Detloff, P. J. (2003) · Gene Expression · doi:10.3727/000000003783992234 · Cited by 25
Analysis of the (CAG)n repeat causing Huntington's disease in a Mexican population
Alonso, M. E., Yescas, P., Cisneros, B., Martínez, C., Silva, G., Ochoa, A., & Montáñez, C. (1997) · Clinical Genetics · doi:10.1111/j.1399-0004.1997.tb02459.x · Cited by 25
Trinucleotide (CAG) repeat expansion in chromosomes of Spanish patients with Huntington's disease
Benitez, J. J., Fernández, E., Ruiz, P., Robledo, M., Ramos, C., & de Yébenes, J. G. (1994) · Human Genetics · doi:10.1007/bf00211028 · Cited by 25
Influence of Age of Onset on Huntington’s Disease Phenotype
Kwa, L., Larson, D., Yeh, C., & Bega, D. (2020) · Tremor and Other Hyperkinetic Movements · doi:10.5334/tohm.536 · Cited by 25
Novel Polyglutamine Model Uncouples Proteotoxicity from Aging
Christie, N. T. M., Lee, A. L., Fay, H. G., Gray, A. A., & Kikis, E. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096835 · Cited by 25
Mutant Huntingtin Gene-Dose Impacts on Aggregate Deposition, DARPP32 Expression and Neuroinflammation in HdhQ150 Mice
Young, D., Mayer, F., Vidotto, N., Schweizer, T., Berth, R., Abramowski, D., Shimshek, D. R., van der Putten, P. H., & Schmid, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075108 · Cited by 24
Oxidized dNTPs and the OGG1 and MUTYH DNA glycosylases combine to induce CAG/CTG repeat instability
Cilli, P., Ventura, I., Minoprio, A., Meccia, E., Martire, A., Wilson, S. H., Bignami, M., & Mazzei, F. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw170 · Cited by 24
Suicidal Ideation Assessment in Individuals with Premanifest and Manifest Huntington Disease
Wesson, M., Boileau, N. R., Perlmutter, J. S., Paulsen, J. S., Barton, S. K., McCormack, M. K., & Carlozzi, N. E. (2018) · Journal of Huntington s Disease · doi:10.3233/jhd-180299 · Cited by 25
The therapeutic potential of G-protein coupled receptors in Huntington's disease
Dowie, M. J., Scotter, E. L., Molinari, E., & Glass, M. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.07.008 · Cited by 26
Molecular mediators, environmental modulators and experience-dependent synaptic dysfunction in Huntington's disease.
Hannan, A. J. (2004) · Acta Biochimica Polonica · doi:10.18388/abp.2004_3581 · Cited by 24
Huntington’s disease: how does huntingtin, an anti-apoptotic protein, become toxic?
Rangone, H., Humbert, S., & Saudou, F. (2004) · Pathologie Biologie · doi:10.1016/j.patbio.2003.06.004 · Cited by 25
CAG‐Repeat length in exon 1 of KCNN3 does not influence risk for schizophrenia or bipolar disorder: A meta‐analysis of association studies
Glatt, S. J., Faraone, S. V., & Tsuang, M. T. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20048 · Cited by 24
Molecular basis and diagnosis of neurogenetic disorders
Müller, U., Graeber, M. B., Haberhausen, G., & Köhler, A. (1994) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)90318-2 · Cited by 24
Huntington disease: Advances in molecular and cell biology
Jones, A. L., Wood, J. D., & Harper, P. S. (1997) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005340302695 · Cited by 24
Huntington’s disease. Part 1: essential background and management
Aubeeluck, A., & Wilson, E. (2008) · British Journal of Nursing · doi:10.12968/bjon.2008.17.3.28402 · Cited by 23
Possible use of a H3R antagonist for the management of nonmotor symptoms in the Q175 mouse model of Huntington's disease
Whittaker, D. S., Wang, H. B., Loh, D. H., Cachope, R., & Colwell, C. S. (2017) · Pharmacology Research & Perspectives · doi:10.1002/prp2.344 · Cited by 22
DNA Methylation Profiles in Whole Blood of Huntington's Disease Patients
Zadel, M., Maver, A., Kovanda, A., & Peterlin, B. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00655 · Cited by 23
The Processing of Emotion in Patients With Huntington's Disease: Variability and Differential Deficits in Disgust
Hayes, C. J., Stevenson, R. J., & Coltheart, M. (2009) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0b013e3181c124af · Cited by 23
Genetic Modifiers of Huntington‘s Disease: Beyond Cag
Arning, L., & Epplen, J. T. (2011) · Future Neurology · doi:10.2217/fnl.11.65 · Cited by 23
Mechanical stress and formation of protein aggregates in neurodegenerative disorders
Hachiya, N., Kozuka, Y., & Kaneko, K. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2007.06.043 · Cited by 24
Senile chorea: a multicenter prospective study
Ruiz, P., Gómez‐Tortosa, E., del Barrio, A., Benitez, J. J., Morales, B., Vela, L., Castro, A., & Requena, I. (1997) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1997.tb00092.x · Cited by 23
Huntington's disease: Silencing a brutal killer
Pfister, E. L., & Zamore, P. D. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.09.017 · Cited by 23
Reevaluation of the exact CAG repeat length in hereditary cerebellar ataxias using highly denaturing conditions and long PCR
Maruyama, H., Kawakami, H., & NAKAMURA, S. (1996) · Human Genetics · doi:10.1007/bf02281866 · Cited by 23
GENETIC MOSAICISM IN THE HOUSE MOUSE
Favor, J., & Neuhäuser-Klaus, A. (1994) · Annual Review of Genetics · doi:10.1146/annurev.ge.28.120194.000331 · Cited by 23
Advances in gene and cellular therapeutic approaches for Huntington’s disease
Piao, X., Li, D., Liu, H., Guo, Q., & Yu, Y. (2024) · Protein & Cell · doi:10.1093/procel/pwae042 · Cited by 23
Are gait initiation parameters early markers of Huntington's disease in pre-manifest mutation carriers?
Delval, A., Bleuse, S., Simonin, C., Delliaux, M., Rolland, B., Destée, A., Defebvre, L., Krystkowiak, P. C., & Dujardin, K. (2011) · Gait & Posture · doi:10.1016/j.gaitpost.2011.04.011 · Cited by 22
PET translates neurophysiology into images: A review to stimulate a network between neuroimaging and basic research
Giovacchini, G., Squitieri, F., Esmaeilzadeh, M., Milano, A., Mansi, L., & Ciarmiello, A. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22451 · Cited by 22
MR‐spectroscopic findings in juvenile‐onset Huntington's disease
Reynolds, N. C., Prost, R. W., Mark, L. P., & Joseph, S. A. (2008) · Movement Disorders · doi:10.1002/mds.22245 · Cited by 22
Exploring the Effect of Sequence Length and Composition on Allele-Selective Inhibition of Human Huntingtin Expression by Single-Stranded Silencing RNAs
Hu, J., Liu, J., Yu, D., Aiba, Y., Lee, S., Pendergraff, H. M., Boubaker-Vitre, J., Artates, J. W., Lagier‐Tourenne, C., Lima, W. F., et al. (2014) · Nucleic Acid Therapeutics · doi:10.1089/nat.2013.0476 · Cited by 22
Transcriptional Regulation of the Huntingtin Gene
Thomson, S. B., & Leavitt, B. R. (2018) · Journal of Huntington s Disease · doi:10.3233/jhd-180331 · Cited by 22
Huntington's Disease and Related Disorders
Anderson, K. E. (2005) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2004.10.001 · Cited by 22
Studies of the CAG repeat in the Machado-Joseph disease gene in Taiwan
Hsieh, M., Tsai, H., Lu, T., Yang, C.-Y., Wu, H., & Li, S.-Y. (1997) · Human Genetics · doi:10.1007/s004390050483 · Cited by 22
Molecular re-investigation of patients with Huntington's disease in Wessex reveals a family with dentatorubral and pallidoluysian atrophy
Connarty, M., Dennis, N. R., Patch, C., MacPherson, J., & Harvey, J. F. (1996) · Human Genetics · doi:10.1007/bf00218837 · Cited by 22
Identification of the spinocerebellar ataxia type 7 mutation in Taiwan: application of PCR-based Southern blot
Hsieh, M., Lin, S., Chen, J.-F., Lin, H.-M., Hsiao, K., Li, S., Li, C., & Tsai, C.-J. (2000) · Journal of Neurology · doi:10.1007/s004150070131 · Cited by 22
Neurogenetic diseases: molecular diagnosis and therapeutic approaches
Müller, U., & Graeber, M. B. (1996) · Journal of Molecular Medicine · doi:10.1007/bf00196782 · Cited by 23
The search for modifier genes in Huntington disease – Multifactorial aspects of a monogenic disorder
Arning, L. (2016) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2016.06.006 · Cited by 21
Cancer: From Wild-Type to Mutant Huntingtin
Thion, M. S., & Humbert, S. (2018) · Journal of Huntington s Disease · doi:10.3233/jhd-180290 · Cited by 21
Protein modification in neurodegenerative diseases
Ramazi, S., Dadzadi, M., Darvazi, M., Seddigh, N., & Allahverdi, A. (2024) · MedComm · doi:10.1002/mco2.674 · Cited by 25
Neuronal oscillations: A physiological correlate for targeting mitochondrial dysfunction in neurodegenerative diseases?
Chan, F., Lax, N. Z., Davies, C. H., Turnbull, D. M., & Cunningham, M. O. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.033 · Cited by 21
Discovery of Therapeutic Approaches for Polyglutamine Diseases: A Summary of Recent Efforts
Esteves, S., Duarte‐Silva, S., & Maciel, P. (2016) · Medicinal Research Reviews · doi:10.1002/med.21425 · Cited by 22
Activation of Caspase-6 Is Promoted by a Mutant Huntingtin Fragment and Blocked by an Allosteric Inhibitor Compound
Ehrnhoefer, D. E., Skotte, N. H., Reinshagen, J., Qiu, X., Windshügel, B., Jaishankar, P., Ladha, S., Petina, O. A., Khankischpur, M., Nguyen, Y. T. N., et al. (2019) · Cell chemical biology · doi:10.1016/j.chembiol.2019.07.001 · Cited by 21
Molecular biology of Huntington's disease
McFarland, K. N., & Cha, J.-H. J. (2011) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52014-2.00003-3 · Cited by 21
Self-citation
Molecular analyses of Machado-Joseph disease
Kobayashi, T., & Kakizuka, A. (2003) · Cytogenetic and Genome Research · doi:10.1159/000072862 · Cited by 21
Characterisation of the unstable expanded CAG repeat in the MJD1 gene in four Brazilian families of Portuguese descent with Machado-Joseph disease
Stévanin, G., Cassa, E., Cancel‐Tassin, G., Abbas, N., Dürr, A., Jardim, E., Agid, Y., Sousa, P. S., & Brice, A. (1995) · Journal of Medical Genetics · doi:10.1136/jmg.32.10.827 · Cited by 21
Study of the Huntington's disease (HD) gene CAG repeats in schizophrenic patients shows overlap of the normal and HD affected ranges but absence of correlation with schizophrenia.
Rubinsztein, D. C., Leggo, J., Goodburn, S. F., Crow, T. J., Lofthouse, R., DeLisi, L. E., Barton, D. E., & Ferguson-Smith, M. A. (1994) · Journal of Medical Genetics · doi:10.1136/jmg.31.9.690 · Cited by 21
Age of onset and behavioral manifestations in Huntington's disease: An Enroll‐HD cohort analysis
Ranganathan, M., Kostyk, S. K., Allain, D. C., Race, J. A., & Daley, A. M. (2021) · Clinical Genetics · doi:10.1111/cge.13857 · Cited by 20
A probable cis-acting genetic modifier of Huntington disease frequent in individuals with African ancestry
Dawson, J., Baine, F., Ciosi, M., Maxwell, A., Monckton, D. G., & Krause, A. (2022) · Human Genetics and Genomics Advances · doi:10.1016/j.xhgg.2022.100130 · Cited by 20

Authors: Duyao, M., Ambrose, C., Myers, R., Novelletto, A., Persichetti, F., Frontali, M., Folstein, S., Ross, C., Franz, M., Abbott, M., Gray, J., Conneally, P., Young, A., Penney, J., Hollingsworth, Z., Shoulson, I., Lazzarini, A., Falek, A., Koroshetz, W., Sax, D., Bird, E., Vonsattel, J., Bonilla, E., Alvir, J., Bickham Conde, J., Cha, J.-H., Dure, L., Gomez, F., Ramos, M., Sanchez-Ramos, J., Snodgrass, S., de Young, M., Wexler, N., Moscowitz, C., Penchaszadeh, G., MacFarlane, H., Anderson, M., Jenkins, B., Srinidhi, J., Barnes, G., Gusella, J., & MacDonald, M.
Affiliations: Massachusetts General Hospital (US)
Boston University (US)
University of Rome Tor Vergata (IT)
Johns Hopkins University (US)
Indiana University (US)
University of Rochester Medicine (US)
Rutgers, The State University of New Jersey (US)
Emory University (US)
Harvard University (US)
Universidad del Zulia (VE)
Long Island Jewish Medical Center (US)
Kennedy Krieger Institute (US)
Hospital Virgen del Camino (ES)
University of Mississippi Medical Center (US)
Hereditary Disease Foundation (US)
ORCID: Myers, R.
Novelletto, A.
Persichetti, F.
Frontali, M.
Ross, C.
Shoulson, I.
Koroshetz, W.
Bonilla, E.
Dure, L.
Snodgrass, S.
Wexler, N.
Gusella, J.
Venue: Nature Genetics
Publisher: Springer Science and Business Media LLC
Published: 1993-08
Volume: 4
Issue: 4
Pages: 387-392
ISSN: 1061-4036 (ISSN-L)
1546-1718
DOI: 10.1038/ng0893-387
OpenAlex: W1994285647
Cited by: 1,089
References: 35
Citations by year: 2026: 17 · 2025: 27 · 2024: 37 · 2023: 23 · 2022: 39 · 2021: 42 · 2020: 36 · 2019: 38 · 2018: 35 · 2017: 42 · 2016: 26 · 2015: 35 · 2014: 31 · 2013: 39 · 2012: 47
FWCI: 17.83
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Genetics (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5r01ns017978-06)
National Institute of Neurological Disorders and Stroke (NS17978, NS16375, NS 16367)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
Keywords: Huntington's disease, trinucleotide repeat expansion, repeat instability, age of onset, paternal transmission, spermatogenesis, presymptomatic diagnosis, repeat length
MeSH terms: Adult, Age Factors, Female, Genetic Carrier Screening, Humans, Huntington Disease, Genetic Linkage, Male, Middle Aged, Pedigree, Repetitive Sequences, Nucleic Acid, Spermatozoa, Linkage Disequilibrium

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Trinucleotide repeat length instability and age of onset in Huntington's disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks